Nothing Special   »   [go: up one dir, main page]

ID27586A - Komposisi aerosol - Google Patents

Komposisi aerosol

Info

Publication number
ID27586A
ID27586A IDW20002207A ID20002207A ID27586A ID 27586 A ID27586 A ID 27586A ID W20002207 A IDW20002207 A ID W20002207A ID 20002207 A ID20002207 A ID 20002207A ID 27586 A ID27586 A ID 27586A
Authority
ID
Indonesia
Prior art keywords
particulate material
aerosol composition
mum
propellant
particles
Prior art date
Application number
IDW20002207A
Other languages
English (en)
Indonesian (id)
Inventor
Paul Alfred Dickinson
Simon John Warren
Original Assignee
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10829846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27586(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Cardiff filed Critical Univ Cardiff
Publication of ID27586A publication Critical patent/ID27586A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IDW20002207A 1998-04-03 1999-04-01 Komposisi aerosol ID27586A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9807232.5A GB9807232D0 (en) 1998-04-03 1998-04-03 Aerosol composition

Publications (1)

Publication Number Publication Date
ID27586A true ID27586A (id) 2001-04-12

Family

ID=10829846

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002207A ID27586A (id) 1998-04-03 1999-04-01 Komposisi aerosol

Country Status (17)

Country Link
US (2) US6737044B1 (zh)
EP (1) EP1069887B8 (zh)
JP (1) JP2002510614A (zh)
KR (1) KR20010072563A (zh)
CN (1) CN1215832C (zh)
AT (1) ATE474555T1 (zh)
AU (1) AU761518B2 (zh)
BR (1) BR9909394A (zh)
CA (1) CA2327336C (zh)
DE (1) DE69942606D1 (zh)
ES (1) ES2349184T3 (zh)
GB (1) GB9807232D0 (zh)
ID (1) ID27586A (zh)
IL (1) IL138770A0 (zh)
MX (1) MXPA00009660A (zh)
WO (1) WO1999051205A1 (zh)
ZA (1) ZA200005374B (zh)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
DE19921693A1 (de) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
AU2001258585B2 (en) * 2000-05-23 2006-12-21 Glaxo Group Limited Aerosol container for formulations of salmeterol xinafoate
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
US20040081627A1 (en) * 2000-10-09 2004-04-29 Jinks Phillip A Medicinal aerosol formulations
HU229899B1 (en) * 2000-12-22 2014-12-29 Glaxo Group Ltd Brentford Metered dose inhaler for salmeterol xinafoate
DE60221640T2 (de) * 2001-02-06 2008-05-21 Innovata Biomed Ltd., St. Albans Bimodale trockenpulverzusammensetzung zur inhalation
WO2002080859A2 (en) * 2001-03-20 2002-10-17 Glaxo Group Limited Inhalation drug combinations
JP2005507881A (ja) * 2001-09-17 2005-03-24 グラクソ　グループ　リミテッド 乾燥粉末医薬製剤
EP1487407A4 (en) * 2002-03-12 2010-08-25 Microdose Therapeutx Inc SITE SPECIFICITY ADMINISTRATION OF MEDICAMENTS SIMULTANEOUSLY TAKEN BY INHALATION
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
GB0219511D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
GB0219512D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions with high drug ratios
MXPA05001903A (es) * 2002-08-21 2005-04-28 Norton Healthcare Ltd Composicion para inhalacion.
CA2496882C (en) * 2002-09-06 2011-11-01 3M Innovative Properties Company Metering valve for a metered dose inhaler providing consistent delivery
US7497214B2 (en) * 2002-09-16 2009-03-03 3M Innovative Properties Company Aerosol dispensers and adaptors therefor
GB0221343D0 (en) * 2002-09-16 2002-10-23 3M Innovative Properties Co Aerosol dispensers and adaptors therefor
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
CN1758930B (zh) 2003-03-27 2010-06-09 株式会社新日本科学 鼻腔用粉末药剂喷药装置
EP1641682B1 (en) * 2003-06-24 2011-01-05 Cipla Limited Pharmaceutical dispensing aid
WO2005051511A1 (ja) * 2003-11-28 2005-06-09 Mitsubishi Chemical Corporation 有機化合物微粒子の製造方法
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
JP2007537833A (ja) * 2004-05-20 2007-12-27 ディスカバリー ラボラトリーズ，インコーポレイテッド 非侵襲的な肺吸入のための方法、システム、及び装置
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
US20060260606A1 (en) * 2005-05-18 2006-11-23 Coifman Robert E Inhalable formulations of amphotericin B and methods and devices for delivery thereof
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
DE102006014433A1 (de) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
US20080269347A1 (en) * 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
US8337817B2 (en) 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
US20080202627A1 (en) * 2007-02-23 2008-08-28 Mas Gregory V Dosing System and Method
PT2230934E (pt) 2007-12-14 2012-11-20 Aerodesigns Inc Distribuir produtos alimentares aerossolizáveis
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2265309B1 (en) 2008-03-17 2015-12-16 Discovery Laboratories, Inc. Ventilation circuit adaptor and proximal aerosol delivery system
EP2179760B1 (en) 2008-10-22 2013-02-27 Trudell Medical International Modular Aerosol Delivery System
US20120064126A1 (en) 2009-03-26 2012-03-15 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
EP2429495A4 (en) 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd INTRANASAL PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PHARMACOKINETICS
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
WO2011066107A1 (en) 2009-11-24 2011-06-03 Gilead Sciences, Inc. Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease
WO2011081937A1 (en) 2009-12-15 2011-07-07 Gilead Sciences, Inc. Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
CN102665807A (zh) 2010-01-05 2012-09-12 微剂量治疗技术公司 吸入设备和方法
UY33373A (es) 2010-05-10 2011-12-30 Gilead Sciences Inc ?Compuestos de pirazolopiridina bifuncionales, su uso en terapia y composiciones que los comprenden?.
UY33372A (es) 2010-05-10 2011-12-30 Gilead Sciences Inc ?análogos de quinolina bi?funcionales, su uso en la manufactura de medicamentos,composiciones que los comprenden y procesos de preparacion?.
CA2809666C (en) 2010-08-30 2020-09-22 Michael M. Lipp Dry powder formulations and methods for treating pulmonary diseases
EP2448571B1 (en) 2010-08-30 2013-06-12 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
CN107096014B (zh) 2010-09-29 2022-07-15 普马特里克斯营业公司 吸入用单价金属阳离子干粉剂
EP3470057B1 (en) 2010-09-29 2021-11-03 Pulmatrix Operating Company, Inc. Cationic dry powders comprising magnesium salt
FR2971772B1 (fr) * 2011-02-17 2013-03-22 Valois Sas Dispositif de distribution de produit fluide.
TWI399202B (zh) 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
FR2973786B1 (fr) * 2011-04-06 2014-07-04 Valois Sas Bague pour dispositif de distribution de produit fluide.
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
WO2013181232A2 (en) 2012-05-29 2013-12-05 Michael Ross Johnson Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
ES2674665T3 (es) 2012-12-17 2018-07-03 Parion Sciences, Inc. Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
BR112015014178A2 (pt) 2012-12-17 2017-07-11 Parion Sciences Inc compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida
WO2014099676A1 (en) 2012-12-17 2014-06-26 Parion Sciences, Inc. Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
CN105473133A (zh) 2013-04-30 2016-04-06 欧缇托匹克公司 干粉制剂及使用方法
PT3104853T (pt) 2014-02-10 2020-01-14 Respivant Sciences Gmbh Tratamento com estabilizadores de mastócitos para distúrbios sistémicos
EP3104854B1 (en) 2014-02-10 2020-04-08 Respivant Sciences GmbH Mast cell stabilizers for lung disease treatment
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
ES2922206T3 (es) 2014-02-20 2022-09-09 Otitopic Inc Formulaciones de polvo seco para la inhalación
PL3179986T3 (pl) 2014-07-31 2023-06-26 Vectura Inc. Suche formulacje w proszku do inhalacji
EP3331522A1 (en) 2015-08-07 2018-06-13 Patara Pharma LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
CA3035528A1 (en) 2016-08-31 2018-03-08 Respivant Sciences Gmbh Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
CN109803724A (zh) 2016-10-07 2019-05-24 瑞思皮万特科学有限责任公司 用于治疗肺纤维化的色甘酸组合物
CN107529499B (zh) * 2017-04-20 2020-06-09 苏州康乐辉医药科技有限公司 一种气雾剂药液浓度稳定装置
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN118695855A (zh) * 2022-01-21 2024-09-24 香港大学 通过单次鼻内施用用于鼻和肺沉积的抗病毒剂的双重靶向粉末制剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3046863A1 (de) 1980-12-12 1982-07-22 Robert Bosch Gmbh, 7000 Stuttgart Elektronisch gesteuertes kraftstoffzumesssystem fuer eine brennkraftmaschine
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
AU5194990A (en) * 1989-02-23 1990-09-26 Rorer International (Holdings), Inc. Therapeutic aerosol formulations
CH680263A5 (zh) 1989-07-20 1992-07-31 Norman Godin
HUT63554A (en) 1990-06-29 1993-09-28 Fisons Plc Aerosol preparations under pressure
ES2064160T3 (es) 1990-10-18 1995-01-16 Minnesota Mining & Mfg Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
GB9024366D0 (en) 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP0561166A1 (de) 1992-03-17 1993-09-22 ASTA Medica Aktiengesellschaft Dosieraerosole enthaltend den Wirkstoff D-18024 und verwandte Strukturen
US5626871A (en) * 1992-06-12 1997-05-06 Teijin Limited Preparation for intratracheobronchial administration
KR100321649B1 (ko) * 1993-03-17 2002-07-22 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
GB9419269D0 (en) * 1994-09-23 1994-11-09 Unilever Plc Aerosol
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
GB2307842A (en) 1995-12-05 1997-06-11 Lin Chan Yen Ventilated protective helmet
RU2101054C1 (ru) 1996-04-30 1998-01-10 Закрытое акционерное общество "Техно-ТМ" Аэрозолеобразующий состав для тушения пожаров и способ его получения
GB9619968D0 (en) 1996-09-25 1996-11-13 Johnson & Johnson Professional Hinge with locking means
SK13632000A3 (sk) * 1998-03-16 2001-03-12 Inhale Therapeutic Systems, Inc. Spôsob podávania aktívnej látky do pľúc ľudského pacienta a zariadenie na jeho vykonávanie
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6136294C1 (en) 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation

Also Published As

Publication number Publication date
IL138770A0 (en) 2001-10-31
CN1303270A (zh) 2001-07-11
JP2002510614A (ja) 2002-04-09
DE69942606D1 (de) 2010-09-02
US7481995B2 (en) 2009-01-27
US20050249674A1 (en) 2005-11-10
EP1069887A1 (en) 2001-01-24
CN1215832C (zh) 2005-08-24
MXPA00009660A (es) 2003-07-14
EP1069887B1 (en) 2010-07-21
EP1069887B8 (en) 2010-08-25
ES2349184T3 (es) 2010-12-28
ATE474555T1 (de) 2010-08-15
AU3162099A (en) 1999-10-25
AU761518B2 (en) 2003-06-05
WO1999051205A1 (en) 1999-10-14
BR9909394A (pt) 2000-12-05
CA2327336A1 (en) 1999-10-14
CA2327336C (en) 2008-07-08
KR20010072563A (ko) 2001-07-31
ZA200005374B (en) 2002-01-03
US6737044B1 (en) 2004-05-18
GB9807232D0 (en) 1998-06-03

Similar Documents

Publication Publication Date Title
ATE474555T1 (de) Aerosol-zusammensetzung
MY119074A (en) Pharmaceutical aerosol composition
DE69907951D1 (de) Verbesserungen in bezug auf pulver
DE60226613D1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
EP0812968A3 (en) Insulating construction material
WO2003024396A3 (en) Dry powder medicament formulations
CA2179645A1 (en) Ultrafine reactive silica particles, suspension containing the same, and hard coating composition
ID25810A (id) Kombinasi berbasis mikrofibril dan partikel mineral, pembuatan dan penggunannya
ES2235311T8 (es) Formulación de budesónida/formoterol para inhalación que tiene una densidad aparente de vertido de 0,30 a 0,36 g/ml, un proceso para preparar la formulación y el uso de la misma.
KR900009728A (ko) 수성도료 조성물 및 이의 용도
NZ508797A (en) Particles of HCV envelope proteins: use for vaccination
HK1085495A1 (en) Spherical powder components and solid cosmetic compositions comprising thereof
AU9313198A (en) Gas generant compositions, methods of production of the same and devices made therefrom
EA200000664A1 (ru) Фармацевтические композиции, содержащие микронизированные бициклические лекарственные средства
DK0685232T3 (da) Cefiximpræparat
WO2000037546A3 (de) Expandierte polypropylen-partikel
TW330870B (en) The powder forming body and its forming method
AR007807A1 (es) Polvo de aspartame para la aplicacion en mezclas de polvos y procedimiento para su preparacion
SE9701278D0 (sv) Pulverformigt biogent, av förbenade hjort framställt preparat och på det biogena preparatet baserad livsmedelstillsats
USD268364S (en) Diaper
DE69820098D1 (de) Diamantpartikel, bestehend aus einem diamantenem kern und einem diamantenem überzug
KR940003549A (ko) 물리적 경피 흡수촉진제 및 이것을 함유하는 첩부제
CA2241039A1 (en) Insulating construction material
WO2002002082A3 (de) Verwendung von dicalciumphosphatanhydrid-pulver
EP1141367B8 (de) Synthetisches nukleinsäure-partikel